182 related articles for article (PubMed ID: 12173128)
1. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.
Feikin DR; Klugman KP
Clin Infect Dis; 2002 Sep; 35(5):547-55. PubMed ID: 12173128
[TBL] [Abstract][Full Text] [Related]
2. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
Gonzalez BE; Hulten KG; Lamberth L; Kaplan SL; Mason EO;
Pediatr Infect Dis J; 2006 Apr; 25(4):301-5. PubMed ID: 16567980
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
[TBL] [Abstract][Full Text] [Related]
4. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
Farrell DJ; Klugman KP; Pichichero M
Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
[TBL] [Abstract][Full Text] [Related]
5. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
6. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
[TBL] [Abstract][Full Text] [Related]
7. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
Jacobs MR; Good CE; Bajaksouzian S; Windau AR
Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
[TBL] [Abstract][Full Text] [Related]
8. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
[TBL] [Abstract][Full Text] [Related]
9. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.
Hausdorff WP; Bryant J; Paradiso PR; Siber GR
Clin Infect Dis; 2000 Jan; 30(1):100-21. PubMed ID: 10619740
[TBL] [Abstract][Full Text] [Related]
10. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
[TBL] [Abstract][Full Text] [Related]
11. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
Motlová J
Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
[TBL] [Abstract][Full Text] [Related]
12. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.
Hausdorff WP; Bryant J; Kloek C; Paradiso PR; Siber GR
Clin Infect Dis; 2000 Jan; 30(1):122-40. PubMed ID: 10619741
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
[TBL] [Abstract][Full Text] [Related]
14. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
Toltzis P; Jacobs MR
Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
[TBL] [Abstract][Full Text] [Related]
16. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.
Huang SS; Platt R; Rifas-Shiman SL; Pelton SI; Goldmann D; Finkelstein JA
Pediatrics; 2005 Sep; 116(3):e408-13. PubMed ID: 16140686
[TBL] [Abstract][Full Text] [Related]
17. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG
J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399
[TBL] [Abstract][Full Text] [Related]
18. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
[TBL] [Abstract][Full Text] [Related]
19. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
